- Rating
- 2
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 1
- Soundness
- 2
Read review
Paper summary
The paper presents RnaProFlo, a conditional generative model that produces single-cell and spatial spot protein levels from paired RNA expression using rectified flow matching in a learned latent token space. Gene and protein tokens are built by modulating expression embeddings with FiLM parameters derived from ESM2 sequence embeddings, which the authors argue allows transfer to proteins and genes absent from training. Dataset and cell metadata are written as text prompts, embedded with Qwen3-Embedding-8B, and injected into DiT-style transformer blocks through AdaLN-Zero. Training proceeds in three stages (encoder/decoder pretraining, latent flow matching, and LoRA joint tuning with a rollout expression loss), and a spatial variant adds gated cross-attention to neighbouring spots’ gene tokens with a Fourier distance bias. The model is trained on about 3.3M cells from 38 CITE-seq and ECCITE-seq datasets and evaluated in zero-shot and fine-tuned settings, including new species, new technologies, a perturbation screen, and spatial CITE-seq, against CAPTAIN, scTranslator, totalVI, scProTrans, and an RNA-as-proxy baseline.
Critical strengths
- Using sequence embeddings to modulate expression gives a principled way to handle protein panels that differ across experiments, and it allows predictions for proteins with no training data (the NEAT-seq experiment), which lookup-table approaches such as CAPTAIN and totalVI cannot make.
- Encoding heterogeneous metadata as text embeddings is a practical answer to the inconsistent metadata fields across public datasets, and the metadata ablations make some attempt to measure its contribution.
- The model is small (1.1M parameters, about 6 hours on one GPU), and the inclusion of a discriminative variant trained under the same pipeline is a useful control that more papers should report.
Critical weaknesses
- The claim to be the first flow-matching single-cell foundation model rests only on a recent non-peer-reviewed review [1]. The paper does not discuss earlier flow-based single-cell generative models such as CFGen.
- The Dataset103_1 zero-shot test count (161,764) equals the training count (145,587) plus the held-out count (16,177), suggesting training cells were evaluated. Zero-shot rows in Tables 2 and 10 also match Table 1 exactly despite supposedly using smaller subsets.
- The paper claims top performance on all datasets, but scTranslator and even the RNA baseline beat RnaProFlo on GSE194122. CAPTAIN-FT and scTranslator-FT also win on the macaque and Perturb-CITE-seq generalization tests.
- Cell prompts include test-set cell type labels and Seurat clusters, which in CITE-seq are often derived from protein data. Baselines get no comparable information, and test-set ablations without these fields are missing.
- Removing the niche attention changes validation cosine only from 0.945 to 0.944 (Table 14). The spatial gains likely come from fine-tuning alone.
[1] Jiang, Shiyu, et al. "The Landscape of Single-Cell Foundation Models: Design Principles, Applications, and Open Challenges." (2026).
Questions for authors
- Since RnaProDisc matches RnaProFlo on every task, what does the flow-matching formulation add? Can you show that generated protein distributions match observed ones, for example with a distributional distance or per-cell variance calibration?
- Why is scProTrans compared only in the zero-shot setting, and how were the abstract’s headline improvements (13.9% cosine, 48.2% MSE) computed?
3 comments
Addressing critical weaknesses (Continued)
5. Removing the niche attention changes validation cosine only from 0.945 to 0.944 (Table 14). The spatial gains likely come from fine-tuning alone.
The original spatial niche ablation was performed on spot-based spatial CITE-seq data. We now compare zero-shot RNAProFlo, fine-tuned RNAProFlo without niche information, and the spatial variant under matched evaluation conditions in new single-cell paired spatial multiomic (RNA–protein) datasets, using held-out protein levels in test subsets.
On renal carcinoma, fine-tuning alone reduces relative MSE from 0.774 to 0.169; adding niche attention further reduces it to 0.160, a 5.3% reduction, while improving all reported metrics. A retrained model using permuted niches obtains relative MSE 0.170, close to the no-niche model.
Thus, fine-tuning accounts for the larger gain, but the matched fine-tuning and permutation controls support a clear additional contribution from spatial neighborhood information.
Response to Reviewer's Questions
- Since RnaProDisc matches RnaProFlo on every task, what does the flow-matching formulation add? Can you show that generated protein distributions match observed ones, for example with a distributional distance or per-cell variance calibration?
Utility of RNAProFlo over RNAProDisc
We expanded our study to evaluate the quality and diversity of the learned conditional protein distributions showing the benefit of stochastic protein generation over deterministic prediction.
We evaluate population distribution fidelity and conditional probabilistic predictive accuracy to assess the contribution of flow matching beyond point prediction. Comparative tables (Table 8-9) and a summarizing figure (Figure 15) is included in the manuscript along with details in A.11 and the added metrics in A.12.
RNAProFlo's population distribution fidelity
The results are shown in Table 8. Protein-wise 1-Wasserstein distance measures agreement between generated and observed marginal distributions across cells, whereas joint compares populations of complete protein profiles. Across the evaluated flow variants, flow-based predictions achieved lower 1-Wasserstein distance than RnaProDisc on 18 of 19 datasets in zero-shot evaluation and 17 of 19 after fine-tuning. was lower on 18 and 15 datasets, respectively, with two additional fine-tuned comparisons tied. These results indicate improved population distribution fidelity.
RNAProFlo's probabilistic predictive accuracy
The results are shown in Table 9. We additionally evaluated continuous ranked probability score (CRPS) and the multivariate energy score against each cell’s measured protein profile, retaining the correspondence between conditioning RNA and predicted proteins. Raw flow samples achieved lower CRPS and energy scores than deterministic RnaProDisc predictions on all 19 datasets in both settings. They also outperformed Gaussian-noise-augmented RnaProDisc on 18 of 19 datasets zero-shot and 16 of 19 after fine-tuning for both metrics. The reported raw-sample scores were consistently lower than those of the flow mean predictions. Together, these findings support the value of retaining sampled variability for probabilistic prediction, alongside improved population distribution fidelity.
Usage guidelines
Across twelve datasets (10 single cell, 2 single cell spatial), RNAProFlo achieved higher dataset-averaged protein cosine, Pearson and Spearman correlations than RNAProDisc by 2.10%, 18.75% and 17.69%, respectively, in zero-shot evaluation. Cell cosine was 8.98% higher and relative MSE was 11.08% lower. After fine-tuning, the corresponding improvements were 0.17%, 8.16% and 6.16% for protein cosine, Pearson and Spearman, alongside 1.31% higher cell cosine, 3.32% higher cell Spearman and 11.32% lower relative MSE. Thus, fine-tuning narrows the cosine differences while RNAProFlo retains advantages in average protein correlations and relative MSE.
RNAProFlo is the default mode for point predictions, sampling protein profiles or probabilistic predictions, given its stronger proper scoring-rule performance and population distribution fidelity. RNAProDisc provides a faster alternative for point prediction, particularly after fine-tuning, where performance differences are often small.
- Why is scProTrans compared only in the zero-shot setting, and how were the abstract’s headline improvements (13.9% cosine, 48.2% MSE) computed?
scProTrans is now included in all relevant benchmarking experiments assessing zero-shot, fine-tuning, limited-data fine-tuning, generalizability and spatial performance.
The abstract's original headline improvements were calculated from the four zero-shot datasets in the original Table 1. For each dataset, we selected the strongest external comparator separately for cosine (highest value) and MSE (lowest value), considering CAPTAIN, scTranslator, scProTrans and totalVI, and excluding RNAProDisc. We then averaged the dataset-specific relative improvements:
Here, and denote RNAProFlo's cosine similarity and MSE, respectively. The quantities and denote the highest cosine similarity and lowest MSE among external comparators for dataset . Both improvements are expressed as percentages.
This yields 13.9% higher cosine and 48.2% lower MSE. However, we have now revised our evaluations and therefore exclude these numbers.
Addressing Critical Weaknesses
We thank the reviewer for their appreciation of our sequence-modulated expression tokenizer, which enables predictions for proteins unseen during training. We agree that our LLM-based metadata embedder overcomes inconsistencies in metadata across datasets. Finally, we thank the reviewer for their appreciation of the small size and runtime requirements of RNAProFlo and the detailed comparisons against its discriminative variant.
1. The claim to be the first flow-matching single-cell foundation model rests only on a recent non-peer-reviewed review [1]. The paper does not discuss earlier flow-based single-cell generative models such as CFGen.
We thank the reviewer for pointing us to CFGen. We have cited it in Section A.1.3 and removed our claim to be the first flow-matching single-cell foundation model.
2. The Dataset103_1 zero-shot test count (161,764) equals the training count (145,587) plus the held-out count (16,177), suggesting training cells were evaluated. Zero-shot rows in Tables 2 and 10 also match Table 1 exactly despite supposedly using smaller subsets.
We thank the reviewer for pointing out this reporting error. No training cells were used for evaluation in any of our experiments. A summary of the cell counts for the datasets in Tables 1, 2 and 10 is provided below.
FT denotes fine-tuning; test counts correspond to the evaluated cells. Dashes indicate settings not evaluated.
3. The paper claims top performance on all datasets, but scTranslator and even the RNA baseline beat RnaProFlo on GSE194122. CAPTAIN-FT and scTranslator-FT also win on the macaque and Perturb-CITE-seq generalization tests.
Thank you for your comment. We agree that our claim was too broad and have revised it to state that we achieve competitive performance across diverse evaluation settings. In addition, we have substantially revised our evaluation framework across metrics and datasets, separating shared evaluations from those not shared by all methods and highlighting evaluations on proteins not seen during training.
Across the eleven sc-datasets (9 single-cell and 2 single-cell spatial) evaluated on common cell and protein panels, RNAProFlo shows broad improvements over external baselines.
Zero-shot: RNAProFlo exceeds scTranslator on all eleven datasets for protein cosine, Pearson, Spearman, cell cosine and relative MSE. It also exceeds scProTrans in protein Pearson and Spearman on every dataset, and CAPTAIN in protein cosine, cell cosine and relative MSE on every dataset.
Fine-tuned: RNAProFlo outperforms the RNA baseline on all six metrics across all eleven datasets. It exceeds scProTrans in protein Pearson and Spearman on nine datasets and CAPTAIN in protein cosine, cell cosine and relative MSE on all eleven.
Overall ranking after fine-tuning: Among all evaluated methods, including RNAProDisc, RNAProFlo ranks among the top two for relative MSE on ten datasets, protein cosine on nine, and each of the remaining four metrics on seven.
These results demonstrate consistent competitiveness across complementary metrics, while acknowledging that other methods lead individual comparisons.
4. Cell prompts include test-set cell type labels and Seurat clusters, which in CITE-seq are often derived from protein data. Baselines get no comparable information, and test-set ablations without these fields are missing.
We thank the reviewer for pointing this out. We reviewed the original publications to determine how cell-type annotations were obtained. Approximately 77% of training datasets and 45% of test datasets used annotations informed by protein measurements, either directly or through multimodal or reference-based analysis.
To address this concern, we removed all cell-type-associated metadata during testing and evaluation and reran the experiments, updating the tables, results and conclusions in the manuscript. In this scenario, training data contains cell types but test/evaluation data does not.